Prolia® Postmarketing Active Safety Surveillance Program for Soliciting Adverse Events of Special Interest in the United States (PASP-EMR Program)First published 16/01/2017 Last updated 22/02/2024 EU PAS number: EUPAS17198StudyFinalised